Literature DB >> 12884428

Spondyloepiphyseal dysplasia Maroteaux type: report of three patients from two families and exclusion of type II collagen defects.

Gen Nishimura1, Rika Kizu, Yoshimaro Kijima, Kiyoshi Sakai, Yoshiharu Kawaguchi, Tomoatsu Kimura, Isao Matsushita, Shuya Shirahama, Toshiyuki Ikeda, Shiro Ikegawa, Tomonobu Hasegawa.   

Abstract

Spondyloepiphyseal dysplasia (SED) Maroteaux type is an autosomal dominant skeletal dysplasia, characterized by spondylar dysplasia, mild epiphyseal dysplasia of the large joints, and type E-like brachydactyly. These manifestations overlap with those of spondyloperipheral dysplasia (SPD), in which a sporadic case with a mutation of COL2A1 has been reported. We report on three patients (an affected woman and her son and a sporadic case of an affected man) with SED Maroteaux type. The affected adults were severely short along with stubby hands and feet, and one developed myelopathy as a result of thoracolumbar gibbus. The affected child was mildly short at birth, and developed brachydactyly in early childhood. The radiological hallmarks of these patients included severe platyspondyly with square-shaped vertebral bodies, iliac hypoplasia, epiphyseal hypoplasia of the large joints, and strikingly short metacarpals and phalanges. These radiological findings appeared already apparent in early childhood. SED Maroteaux type was radiologically discriminative from SPD. Brachydactyly was much severe in the former than in the latter, and spondylar dysplasia manifestation was different between both disorders. Mutation screen by polymerase chain reaction-direct sequencing for all exons and their flanking regions of COL2A1 did not reveal any mutations in the three patients. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12884428     DOI: 10.1002/ajmg.a.20095

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  1 in total

1.  Spondyloepimetaphyseal dysplasia-Maroteaux type due to dominant TRPV4 mutation: expanding the phenotype with a case report.

Authors:  Ceren Yılmaz Uzman; Tufan Çankaya; Handan Güleryüz; Ayfer Ülgenalp; Özlem Giray Bozkaya
Journal:  Skeletal Radiol       Date:  2022-07-01       Impact factor: 2.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.